Xlife Sciences AG Capital Reinvestment Ratio
Xlife Sciences AG capital reinvestment ratio. Xlife Sciences AG (XLS) has a Capital Reinvestment Ratio of 0.24x as of December 2023, meaning it reinvests 0% of its operating cash flow (CHF171.78K) in capital expenditures (CHF41.08K). Check Xlife Sciences AG investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Xlife Sciences AG (2023–2023)
Capital reinvestment ratio of Xlife Sciences AG from 2023 to 2023. This chart tracks Xlife Sciences AG's Capital Reinvestment Ratio across 1 annual periods. Also explore net asset momentum of Xlife Sciences AG to track the company's year-over-year net asset growth rate.
Xlife Sciences AG Capital Reinvestment Ratio by Year (2023–2023)
Xlife Sciences AG capital reinvestment ratio by year from 2023 to 2023. For the full cash flow conversion analysis, see Xlife Sciences AG cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.24x | CHF171.78K | CHF41.08K | — |